Wholesale of pharmaceutical and medical goods
CAEDO ONCOLOGY AS
Revenue 2024
NOK 0
Operating profit
NOK −3.7m
Equity
NOK 28.6m
Incorporated
2020
Share capital
NOK 165,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 0 | |
| Total operating costs | 3.7m | |
| Operating profit (EBIT) | −3.7m | |
| Net financial items | 65k | |
| Profit for the year | −3.6m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 42.6m | |
| of which current assets | 7.4m | |
| Equity | 28.6m | |
| Total liabilities | 14.0m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.